First of its kind blood test to measure immune response to COVID vaccine in immunocompromised patients
The Penn Medicine-created test measures both antibody and T-cell response to COVID-19 vaccination among multiple sclerosis patients, then integrates results into the electronic health record to aid in clinician and patient decision-making.
FULL STORY AT Penn Medicine News →